1080 related articles for article (PubMed ID: 29782316)
21. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
22. Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's Disease.
Zhao Q; Guo Q; Liang X; Chen M; Zhou Y; Ding D; Hong Z
Curr Alzheimer Res; 2015; 12(6):520-6. PubMed ID: 26027810
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Sierra-Rio A; Balasa M; Olives J; Antonell A; Iranzo A; Castellví M; Bosch B; Grau-Rivera O; Fernandez-Villullas G; Rami L; Lladó A; Sánchez-Valle R; Molinuevo JL
Neurodegener Dis; 2016; 16(1-2):69-76. PubMed ID: 26560503
[TBL] [Abstract][Full Text] [Related]
24. KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment.
Mazzeo S; Bessi V; Padiglioni S; Bagnoli S; Bracco L; Sorbi S; Nacmias B
Neurol Sci; 2019 Aug; 40(8):1559-1566. PubMed ID: 30953258
[TBL] [Abstract][Full Text] [Related]
25. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
26. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
[TBL] [Abstract][Full Text] [Related]
27. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
[TBL] [Abstract][Full Text] [Related]
28. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
[TBL] [Abstract][Full Text] [Related]
29. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
30. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
[TBL] [Abstract][Full Text] [Related]
32. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.
Bartrés-Faz D; Junqué C; López-Alomar A; Valveny N; Moral P; Casamayor R; Salido A; Bel C; Clemente IC
J Am Geriatr Soc; 2001 Jul; 49(7):985-90. PubMed ID: 11527492
[TBL] [Abstract][Full Text] [Related]
34. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
35. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
[TBL] [Abstract][Full Text] [Related]
36. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
[TBL] [Abstract][Full Text] [Related]
37. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
38. Gender differences in cognitive reserve: implication for subjective cognitive decline in women.
Giacomucci G; Mazzeo S; Padiglioni S; Bagnoli S; Belloni L; Ferrari C; Bracco L; Nacmias B; Sorbi S; Bessi V
Neurol Sci; 2022 Apr; 43(4):2499-2508. PubMed ID: 34625855
[TBL] [Abstract][Full Text] [Related]
39. PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
Mazzeo S; Lassi M; Padiglioni S; Vergani AA; Moschini V; Scarpino M; Giacomucci G; Burali R; Morinelli C; Fabbiani C; Galdo G; Amato LG; Bagnoli S; Emiliani F; Ingannato A; Nacmias B; Sorbi S; Grippo A; Mazzoni A; Bessi V
BMC Neurol; 2023 Aug; 23(1):300. PubMed ID: 37573339
[TBL] [Abstract][Full Text] [Related]
40. Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.
Grande G; Vanacore N; Vetrano DL; Cova I; Rizzuto D; Mayer F; Maggiore L; Ghiretti R; Cucumo V; Mariani C; Cappa SF; Pomati S
Neurol Sci; 2018 Nov; 39(11):1867-1875. PubMed ID: 30051200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
